Gland Pharma Ltd.

NSE: GLAND | BSE: 543245 | ISIN: INE068V01023 | Industry: Pharmaceuticals
| Mid-range Performer
1689.7000 20.30 (1.22%)
NSE Jun 13, 2025 15:31 PM
Volume: 88,073
 

logo
Gland Pharma Ltd.
09 Aug 2023
1689.70
1.22%
Axis Direct
Injectable companies (HIKMA, HOSIPORA, and Aurobindo) in the US market reported sales growth of ~4% YoY. We expect similar growth for GLAND in the core markets over a longer period and high single-digit growth in India and RoW over a long-term.
Gland Pharma Ltd. has gained 17.90% in the last 1 Month
More from Gland Pharma Ltd.
Recommended